<!-- FILE: topics/06-calcium-phosphorus-bone.html -->
<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Bone Metabolism & Electrolytes | Clinical Chemistry</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="05-liver-function.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Liver Function</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">6</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">10</span>
                            </div>
                            <span class="progress-label">Bone & Calcium</span>
                        </div>
                        
                        <a href="07-fluids-electrolytes-acid-base.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Fluids & Electrolytes</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Calcium, Phosphorus & Bone Metabolism</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">ü¶¥</span>
                        <span class="badge-text">Metabolic Bone Disease</span>
                    </div>
                    <h1 class="document-title">Calcium (CAL) and Phosphorus (PHOS) Metabolism and Related Disorders</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Topic Six</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>30 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">

                    <!-- START: calcium-metabolism -->
                    <section id="calcium-metabolism" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Calcium Metabolism</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Calcium is a mineral that helps build strong bones and teeth. Calcium and phosphorus in the mineral phase of the hard tissue i.e. bone and teeth co-exist in a relatively fixed proportions. The three main regulators of calcium and phosphorus homeostasis are parathyroid hormone,vitamin D and calcitonin each exert independent effects on both ions. Intracellularly, calcium is the prime inorganic messenger for regulation of cell functions. Calcium is needed throughout an individual's life and the amount required changes over time. A lot of calcium is required during childhood years to build strong bone, a bit less during the middle years to keep bones strong, and much later in life to prevent bone loss.</p>
                            
                            <h3>Disorders of Calcium Levels</h3>
                            <p>Pathological conditions associated with calcium levels in blood are hypercalcaemia and hypocalcaemia. These are determined in relation to the reference ranges of calcium in a particular population.</p>
                            
                            <h4>Hypercalcemia</h4>
                            <p>Hypercalcemia is a condition of elevated levels of calcium in plasma and it is a common metabolic abnormality frequently related to primary hyperparathyroidism and cancer. Hypercalcaemia affects 8 in 100,000 individuals and it common between the ages 40-50 years. In relation to gender, females are more affected than males. Studies have identified hypercalcaemia as a complication in critically ill patient with adrenal insufficiency. Hypercalcemia has been reported to occur not only with primary hypoadrenalism but also with secondary hypoadrenalism .</p>
                            
                            <h4>Hypocalcemia</h4>
                            <p>Hypocalcaemia is a condition of low calcium levels in plasma. It manifests as a symptom of. Hypocalcemia is a common condition characterized by a net loss of calcium from extracellular fluid in greater quantities than can be replaced by the intestine or bone. Hypocalcemia is caused by a number of clinical entities eg a parathyroid hormone [PTH] deficiency/malfunction, a Vitamin D deficiency, or unusually high magnesium levels hypermagnesaemia, or low magnesium levels hypomagnesaemia and often presents with signs of generalized neuromuscular irritability including paresthesia, muscle cramps, laryngospasm, tetany, and seizures. Osteomalacia (adults) and rickets (children) are disease conditions encountered in hypocalcaemia and similar to hypophosphotaemia.</p>
                        </div>
                    </section>
                    <!-- END: calcium-metabolism -->

                    <!-- START: phosphorus-metabolism -->
                    <section id="phosphorus-metabolism" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">Phosphorus Metabolism</h2>
                        </div>

                        <div class="content-card">
                            <p>Phosphorus is also an abundant element in the body. At least 85% is found in the bone whilst the other 15% is found mostly combined with lipids proteins, carbohydrates and other organic substances. Most phosphorus in the extracellular fluid is inorganic. Major organs involved in phosphorus homeostasis are small intestines, kidneys and the skeleton, which acts as a storage reservoir. Phosphorus is present virtually in all foods. Consequently dietary deficiencies do not occur. Dietary intake is between 800-1000 mg for adults and is mostly from milk and other dairy product.</p>
                            
                            <h3>Disorders of Phosphorus Levels</h3>
                            <p>Pathological conditions related to phosphorus are hypophosphotaemia (reduced phosphorus levels) and hyperphosphotaemia (elevated phosphorus levels).</p>
                            
                            <h4>Hypophosphotaemia</h4>
                            <p>Hypophosphotaemia is a common condition is critically ill patient and its aetiology multifactorial. Phosphate plays an important role in the glycolysis and the production of high energy compounds such as Adenosine tri-phosphate (ATP). Evidence of its depletion in critically ill patients may manifest itself as impairment in respiratory, cardiovascular, neuromuscular and haematological function.</p>
                            <p>Osteomalacia (adults) and rickets (children) are caused by an inadequate supply of vitamin D leading to inadequate mineralisation of bone matrix. Vitamin D deficiency is most often caused by nutritional deficiency but can be secondary to a wide range of other underlying causes, such as disorders of the gut, pancreas, liver and kidney. Vitamin D deficiency causes a low calcium and phosphate, which lead to secondary hyperparathyroidism. Normal bone mineralisation depends on adequate calcium and phosphate and this is maintained by vitamin D. Vitamin D is supplied either in the diet or produced from a precursor in the skin following exposure to ultraviolet light. 90% of our daily vitamin D requirement is usually obtained by the action of sunlight on the skin and 10% is obtained from the diet. It has been estimated that 1 billion people worldwide have vitamin D deficiency. One study found the prevalence of rickets in non-Caucasian children to be 1.6%. In the United Kingdom, the prevalence of vitamin D insufficiency in all adults is about 14.5% and possibly more than 30% in those over 65 years old.</p>
                            
                            <h4>Hyperphosphatemia</h4>
                            <p>Hyperphosphatemia is an electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood. Often, calcium levels are lowered (hypocalcemia) due to precipitation of phosphate with the calcium in tissues. Chronic renal failure is a cause of hyperphosphotaemia whereby kidneys aren't working well, there is increased phosphate retention. Drugs can also cause hyperphosphatemia e.g taking oral sodium phosphate solutions prescribed for bowel preparation for colonoscopy in children. Studies have shown the association of hyperphosphotaemia with increased mortality in patient with end stage renal disease undergoing hamodialysis. In these patients, hyperphosphotaemia causes cardiovascular calcification CVC has been linked to an increased risk of cardiovascular events, including myocardial infarction, fatal arrhythmia, congestive heart failure, and valvular heart disease.</p>
                        </div>
                    </section>
                    <!-- END: phosphorus-metabolism -->

                    <!-- START: hormonal-regulation -->
                    <section id="hormonal-regulation" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">Hormonal Regulation</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>The three primary regulators of calcium and phosphorus are parathyroid hormone(PTH), calcitonin(CT) and 1,25dihydroxyvitamin D(1,25-(OH)<sub>2</sub>D</p>

                            <details class="collapsible-section" open>
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Parathyroid Hormone (PTH)</span>
                                </summary>
                                <div class="collapsible-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Synthesized by the parathyroid glands located on the posteriorsurface of the thyroid gland.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Its primary role is the regulation of ECF calcium concentration. Synthesis and secretion of PTH is under precisefeedback regulation by the concentration of ionized calcium in the circulation.PTH synthesis and secretion are stimulated within a few minutes by low concentration of calcium whilst high concentration of calcium suppresses secretion.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">although PTH affects the concentration of phosphorus in the circulation, high or low levels of phosphorus does not have a direct effect on the secretion of PTH.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">It stimulates osteoclasts to mobilize calcium from bones</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">it increases renal tubular reabsorption of calcium</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">It inhibits proximal renal tubular reabsorption of phosphorus it promotes bone formation in certain circumstances after PTH binds to membrane receptors of target organs</span></li>
                                    </ul>
                                    <p><strong>THE NET EFFECTS OF PTH ARE INCREASES IN PLASMA CALCIUM AND A DECREASE IN PHOSPHORUS CONCENTRATION.</strong></p>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Calcitonin</span>
                                </summary>
                                <div class="collapsible-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Produced by C cells of the thyroid gland.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">it role is to decrease resorption of calcium and phosphorus from bone by inhibiting the action of osteoclasts leading to lower plasma levels of calcium and phosphorus.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">CT has its greatest physiological effect in the fetus and young children, probably because bone calcium turn over is very rapid at this stage of development.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">plasma CT levels are are higher in neonate and in pregnant and lactating women than in normal adults. CT may have a function in promoting deposition of calcium in the skeleton of the human fetus and may be a causative factor in neonatal hypocalcemia.</span></li>
                                    </ul>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Vitamin D and its Metabolites</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p>There are two families: VIT D<sub>3</sub> (cholecalciferol)-is the natural form produced by the skin from the action of sunlight. VIT D<sub>2</sub> (Ergocalciferol)-manufactured commercially from precursors of plant origin.</p>
                                    <p>-to exert its physiological action, Vit D must undergo two hydroxylations both of which are catalyzed by specific hydroxylases (OHase) . The first takes place in the liver where Vit D is converted to 25 -hydroxyvitamin D (25-(OH)D . The latter is transported to the kidney by vit d binding proteins, where it undergoes further hydroxylation to either 1,25-dihydroxyvitamin D(1,25-(OH)<sub>2</sub>D) or 24,25-dihydroxyvitamin D(24,25-(OH)<sub>2</sub>D.</p>
                                    <p>FUNCTION: - Vit D----(1,25-(OH)2---1,25-(dihydroxyvitamin D)-is the most potent of the known metabolite of vit D . It has a rapid and powerful stimulatory action on membrane transport of calcium. When calcium mobilization is required, 1-OHase activity is stimulated and synthesis of 1,25-(OH)2 D takes place. When calcium mobilization is unnecessary or would be detrimental to the individual, 1 -hydroxylation ceases and 25-(OH)D is converted to inactive 24,25-(OH)<sub>2</sub>D.</p>
                                    <p>1,25-(OH)<sub>2</sub>D has the following biological actions:</p>
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Stimulates calcium absorption by the small intestine</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Stimulates phosphorus absorption by the small intestine</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Stimulates calcium resorption from bones, in this action,PTH acts synergistically</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">It increases calcium reabsorption by the distal renal tubules.</span></li>
                                    </ul>
                                    <p>In summary, the net effect of 1,25-(OH)2 D , is an increase in plasma calcium and phosphate concentrations.</p>
                                </div>
                            </details>
                        </div>

                        <div class="content-card">
                            <h3 id="regulation-overview">Regulation of Calcium and Phosphorus Metabolism</h3>
                            <p>The concentration of calcium and phosphorus in plasma are determined by the balance between absorption and excretion in the kidneys, the intestine and to a small extent the skin, and by exchanges between plasma, ECF and tissues including bone.</p>
                            <p>These dynamic processes are determined by many factors , principally parathyroid hormone (PTH),calcitonin (CT) and vitamin D. The actions of these three hormones results in a remarkably precise control of the plasma calcium concentration in healthy individuals.</p>
                            <p>In the case of plasma phosphorus concentration regulation, PTH exerts a particularly important effect by inhibiting phosphate reabsorption by the kidney tubules. Therefore PTH lowers the plasma phosphorus concentration.</p>
                        </div>
                    </section>
                    <!-- END: hormonal-regulation -->

                    <!-- START: bone-diseases -->
                    <section id="bone-diseases" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">Calcium, Phosphorus Related Disorders</h2>
                        </div>
                        
                        <div class="content-card">
                            <h3 id="rickets-osteomalacia">Rickets (AND Osteomalacia)</h3>
                            <p>Is a softening of bones in children due to deficiency or impaired metabolism of vitamin D, phosphorus or calcium, potentially leading to fractures and deformity. Rickets is among the most frequent childhood diseases in many developing countries. The predominant cause is a vitamin D deficiency, but lack of adequate calcium in the diet may also lead to rickets (cases of severe diarrhea and vomiting may be the cause of the deficiency). Although it can occur in adults, the majority of cases occur in children suffering from severe malnutrition, usually resulting from famine or starvation during the early stages of childhood.Osteomalacia is a similar condition occurring in adults, generally due to a deficiency of vitamin D.</p>
                            
                            <h4>Further Notes on Rickets</h4>
                            <p>Young babies with rickets can be fussy and have soft skulls. Infants and toddlers may not develop, walk, or grow well. Older children may have bone pain and bowed legs, or their wrists and knees may get wider.</p>
                            <p>The most common cause of rickets is a lack of vitamin D or calcium in a child's diet. Both are essential for children to develop strong and healthy bones. Sources of vitamin D are: sunlight your skin produces vitamin D when it's exposed to the sun, and we get most of our vitamin D this way.<br>
                            To prevent rickets, make sure your child eats foods that contain vitamin D naturally - fatty fish such as salmon and tuna, fish oil and egg yolks - or that have been fortified with vitamin D, such as: Infant formula. Cereal.<br>
                            Vitamin D deficiency rickets among breastfed infants is rare, but it can occur if an infant does not receive additional vitamin D from foods, a vitamin D supplement, or adequate exposure to sunlight.<br>
                            Symptoms of hypocalcemia depend on how low the baby's calcium is and how fast the drop happened.</p>
                            
                            <h5>What Are the Signs & Symptoms of Hypocalcemia in Babies?</h5>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">be fussy.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">vomit.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">seem weak or floppy.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">twitch, shake, or seem jittery.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">not feed well.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">be sluggish.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">have seizures.</span></li>
                            </ul>

                            <h4>Further Notes on Osteomalacia</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">This condition is similar to rickets BUT the condition affects adults</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">As define under rickets, the condition has to do with softening of bone tissue., typically through a deficiency of vitamin D or calcium.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Osteomalacia is softening of the bones. It most often occurs because of a problem with vitamin D, which helps your body absorb calcium. Your body needs calcium to maintain the strength and hardness of your bones</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">As osteomalacia progresses, you might develop bone pain and muscle weakness. The dull, aching pain associated with osteomalacia most commonly affects the lower back, pelvis, hips, legs and ribs. The pain might be worse at night or when you put pressure on the bones. The pain is rarely relieved completely by rest.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Fortunately, getting enough vitamin D through oral supplements for several weeks to months can cure osteomalacia. To maintain normal blood levels of vitamin D, you'll likely have to continue taking the supplements</span></li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="osteoporosis">Osteoporosis</h3>
                            <p>Describes a group of diseases of diverse causes that are characterized by the reduction of bone mass that is required for normal mechanical function even though the ration of mineral to the organic matter is normal.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">It can be secondary to well defined condations such as cushings disease, glucorticoid administration and chronic immobilization. Most often it is primary and not associated to any definite disease.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Idiopathic osteoporosis is the most common skeletal abnormality in post menopause women and it is frequently seen in aged individuals.</span></li>
                            </ul>
                            <p><strong>LAB FINDINGS</strong>----- Normal calcium and phosphorus. Raised calcium when the pt is immobilized and raised ALP in a pt that has a fractured bone.</p>
                            
                            <h4>Further Notes on Osteoporosis</h4>
                            <p>A medical condition in which the bones become brittle and fragile from loss of tissue, typically as a result of hormonal changes, or deficiency of calcium or vitamin D.<br>
                            The main cause of osteoporosis is bone loss due to a drop in your body's estrogen levels. Estrogen is a hormone that helps build and maintain your bones. The most common cause of estrogen loss in women is menopause.</p>
                            
                            <h5>Symptoms</h5>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Back pain, caused by a fractured or collapsed vertebra.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Loss of height over time.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">A stooped posture.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">A bone that breaks much more easily than expected.</span></li>
                            </ul>
                            <p>Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications</p>
                        </div>

                        <div class="content-card">
                            <h3 id="pagets-disease">Paget's Disease of the Bone Tissue</h3>
                            <p>Paget's disease of bone is a chronic disease of the skeleton. In healthy bone, a process called remodeling removes old pieces of bone and replaces them with new, fresh bone. Paget's disease causes this process to shift out of balance, resulting in new bone that is abnormally shaped, weak, and brittle.</p>
                            <p>This is a non metabolic bone disease characterized by excessive bone resorption and repair , increased turn over of bone minerals and matrix and formation of abnormal bones .Evidence of viral origin has recently been presented..</p>
                        </div>
                    </section>
                    <!-- END: bone-diseases -->

                    <!-- START: disorders-ca-p -->
                    <section id="disorders-ca-p" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">Disorders of Calcium and Phosphorus</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>The disorders are hypercalcaemia, hyperphosphataemia, hypocalcaemia ,and hypophosphotaemia.</p>
                            <p>Hypercalcaemia is associated with hyperparathyroidism. Most patients with primary hyperparathyroidism are either asymptomatic or have fatigue, weakness, anorexia, nausea and vomitingwhich are present if hypercalcaemia is protracted and severe.</p>

                            <h4>Hypercalcaemia and Malignancy</h4>
                            <p>High levels of calcium occurs in 10-20 %of patients with malignant diseases. Malignant associated with hypercalcaemia are classified in three categories ie either SOLID, TUMORS (secretes a humorol factor with PTH like activity), SOLID NON SECRETING TUMORS withskeletal metastasis, HAEMATOLOGIC MALIGANCY( multiple myeloma, lymphoma and leukemia are most common neoplasia.</p>

                            <h4>Diseases Associated with Hypocalcaemia</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypoparathyroidism---due to deficient secretion of PTH. Causes could be due to advertent removal or damage during thyriodectomy or an autoimmune destruction of the glands.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">low calcium could be due to vit d deficiency.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Heriditary vit d dependency rickets type 1 and 2 .</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Intestinal malabsorption could lead to rickets(children) or oesteomalacia(adults)</span></li>
                            </ul>

                            <h4>Hyperphosphataemia</h4>
                            <p>RENAL OSTEODYSTROPHY-This refers to skeletal lesions that occur in CRF. Rickets, osteomalacia, hyperparathyroidism, osteosceleria, and osteoporosis are found in varying degrees.<br>
                            In CRF the ability of the kidney to excrete inorganic phosphorus is greatly impaired and hyperphosphataemia results.</p>

                            <h4>Hypophosphataemia</h4>
                            <p>Rickets and osteomalacia may occur in chronic hypophosphataemia..</p>
                        </div>
                    </section>
                    <!-- END: disorders-ca-p -->

                    <!-- START: magnesium -->
                    <section id="magnesium" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">06</div>
                            <h2 class="section-title">Magnesium (MG) Metabolism and Related Disorders</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Magnesium is one of the major intracellular cation. It is an essential factor in many important enzymatic reactions, either as an integral part of a metal-coenzyme or as an activator. The best defined manifestation of magnesium deficiency is impairment of neuromuscular function e.g., hyperirritability, tetany, convulsions and electrocardiographic changes. Conditions associated with hypomagnesaemia (reduced magnesium blood levels) include chronic alcoholism, childhood malnutrition, lactation, malabsorption, acute pancreatitis, hypoparathyroidism, aldosteronism and prolonged intravenous feeding (Lu and Nightingale, 2000). Increased levels of magnesium (hypermagnesaemia) have been observed in dehydration, severe diabetic acidosis and Addison's disease. Conditions that interfere with glomerular filtration .e.g., renal failure, result in retention of magnesium and hence elevation of plasma levels.</p>
                            <p><strong>SPECIMENS OF CHOICE</strong> ; Heparinized plasma, serum</p>
                            <p><strong>Reference range in literature</strong> ( 0.9-1.1 mmol/L</p>
                        </div>
                    </section>
                    <!-- END: magnesium -->

                    <!-- START: laboratory-analysis -->
                    <section id="laboratory-analysis" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">07</div>
                            <h2 class="section-title">Laboratory Analytical Methods</h2>
                        </div>
                        
                        <div class="content-card">
                            <h3 id="calcium-analysis">Calcium (CAL)</h3>
                            <p>Calcium has two methods of analysis namely (i) o-Cresolphthalein (oCPC) and (ii) Arsenazo III ( 2,2'-[ 1,8-Dihydroxy-3,6- disulphonaphthylene-2,7-bisazo] bisbenzenearsonic acid) which are used widely in diagnostic laboratory.</p>
                            <p><strong>SPECIMENS OF CHOICE</strong> ; Heparinized plasma, serum</p>
                            <p>Nb/EDTA (ethylenediamine tetra-acetic acid) plasma should not be used since the anti coagulant (EDTA) chelating affect of binding calcium will clear calcium from the solution therefore no reaction will take place.</p>
                            <p><strong>Reference range in literature</strong> ( 2.02-2.6 mmol/L )</p>

                            <h3 id="phosphorus-analysis">Phosphorus (PHOS)</h3>
                            <p>Phosphorus reagent is used to measure the phosphorus concentration by a timed end point method.</p>
                            <p><strong>SPECIMENS OF CHOICE</strong> ; Heparinized plasma, serum</p>
                            <p><strong>Reference range in literature</strong> ( 1.03 - 2.3 mmol/L )</p>
                        </div>
                    </section>
                    <!-- END: laboratory-analysis -->

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="05-liver-function.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Liver Function</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="07-fluids-electrolytes-acid-base.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Fluids & Electrolytes</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>